112 related articles for article (PubMed ID: 18679005)
1. Aquaporin 4 mRNA levels in neuromuscular tissues of wild-type and dystrophin-deficient mice.
Shibuya S; Hara H; Wakayama Y; Inoue M; Jimi T; Matsuzaki Y
Tohoku J Exp Med; 2008 Aug; 215(4):313-9. PubMed ID: 18679005
[TBL] [Abstract][Full Text] [Related]
2. Voltage-gated sodium channel (SkM1) content in dystrophin-deficient muscle.
Ribaux P; Bleicher F; Couble ML; Amsellem J; Cohen SA; Berthier C; Blaineau S
Pflugers Arch; 2001 Mar; 441(6):746-55. PubMed ID: 11316257
[TBL] [Abstract][Full Text] [Related]
3. Aquaporins in skeletal muscle: reassessment of the functional role of aquaporin-4.
Frigeri A; Nicchia GP; Balena R; Nico B; Svelto M
FASEB J; 2004 May; 18(7):905-7. PubMed ID: 15033928
[TBL] [Abstract][Full Text] [Related]
4. Assessing the Role of Aquaporin 4 in Skeletal Muscle Function.
Aslesh T; Al-Aghbari A; Yokota T
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675000
[TBL] [Abstract][Full Text] [Related]
5. Generation of muscle aquaporin 4 overexpressing transgenic mouse: its characterization at RNA and protein levels including freeze-fracture study.
Wakayama Y; Takahashi J; Shibuya S; Inoue M; Kojima H; Oniki H; Arata S; Hara H; Jimi T; Shioda S; Sunada Y; Ohi H; Shimizu T
Micron; 2007; 38(3):257-67. PubMed ID: 16820300
[TBL] [Abstract][Full Text] [Related]
6. Aquaporin-4 deficiency in skeletal muscle and brain of dystrophic mdx mice.
Frigeri A; Nicchia GP; Nico B; Quondamatteo F; Herken R; Roncali L; Svelto M
FASEB J; 2001 Jan; 15(1):90-98. PubMed ID: 11149896
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle function and water permeability in aquaporin-4 deficient mice.
Yang B; Verbavatz JM; Song Y; Vetrivel L; Manley G; Kao WM; Ma T; Verkman AS
Am J Physiol Cell Physiol; 2000 Jun; 278(6):C1108-15. PubMed ID: 10837338
[TBL] [Abstract][Full Text] [Related]
8. Characterization of aquaporin-4 in muscle and muscular dystrophy.
Crosbie RH; Dovico SA; Flanagan JD; Chamberlain JS; Ownby CL; Campbell KP
FASEB J; 2002 Jul; 16(9):943-9. PubMed ID: 12087055
[TBL] [Abstract][Full Text] [Related]
9. Different pattern of aquaporin-4 expression in extensor digitorum longus and soleus during early development.
Nicchia GP; Mola MG; Pisoni M; Frigeri A; Svelto M
Muscle Nerve; 2007 May; 35(5):625-31. PubMed ID: 17266129
[TBL] [Abstract][Full Text] [Related]
10. Effects of prednisolone on the dystrophin-associated proteins in the blood-brain barrier and skeletal muscle of dystrophic mdx mice.
Tamma R; Annese T; Capogrosso RF; Cozzoli A; Benagiano V; Sblendorio V; Ruggieri S; Crivellato E; Specchia G; Ribatti D; De Luca A; Nico B
Lab Invest; 2013 May; 93(5):592-610. PubMed ID: 23528847
[TBL] [Abstract][Full Text] [Related]
11. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of neural stem cells from dystrophic mdx mouse.
Annese T; Corsi P; Ruggieri S; Tamma R; Marinaccio C; Picocci S; Errede M; Specchia G; De Luca A; Frassanito MA; Desantis V; Vacca A; Ribatti D; Nico B
Exp Cell Res; 2016 May; 343(2):190-207. PubMed ID: 27015747
[TBL] [Abstract][Full Text] [Related]
13. Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients.
Au CG; Butler TL; Egan JR; Cooper ST; Lo HP; Compton AG; North KN; Winlaw DS
Acta Neuropathol; 2008 Sep; 116(3):235-46. PubMed ID: 18392839
[TBL] [Abstract][Full Text] [Related]
14. Reduced aquaporin 4 expression in the muscle plasma membrane of patients with Duchenne muscular dystrophy.
Wakayama Y; Jimi T; Inoue M; Kojima H; Murahashi M; Kumagai T; Yamashita S; Hara H; Shibuya S
Arch Neurol; 2002 Mar; 59(3):431-7. PubMed ID: 11890849
[TBL] [Abstract][Full Text] [Related]
15. Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotides.
Rando TA; Disatnik MH; Zhou LZ
Proc Natl Acad Sci U S A; 2000 May; 97(10):5363-8. PubMed ID: 10805797
[TBL] [Abstract][Full Text] [Related]
16. The influence of muscle type and dystrophin deficiency on murine expression profiles.
Haslett JN; Kang PB; Han M; Kho AT; Sanoudou D; Volinski JM; Beggs AH; Kohane IS; Kunkel LM
Mamm Genome; 2005 Oct; 16(10):739-48. PubMed ID: 16261416
[TBL] [Abstract][Full Text] [Related]
17. Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice.
Mueller GM; O'Day T; Watchko JF; Ontell M
Hum Gene Ther; 2002 Jun; 13(9):1081-90. PubMed ID: 12067441
[TBL] [Abstract][Full Text] [Related]
18. PCR analysis of dystrophin gene mutation and expression.
Chamberlain JS; Farwell NJ; Chamberlain JR; Cox GA; Caskey CT
J Cell Biochem; 1991 Jul; 46(3):255-9. PubMed ID: 1774226
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement.
Kapsa R; Quigley A; Lynch GS; Steeper K; Kornberg AJ; Gregorevic P; Austin L; Byrne E
Hum Gene Ther; 2001 Apr; 12(6):629-42. PubMed ID: 11426463
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of aquaporin 4 in human muscles with amyotrophic lateral sclerosis and other neurogenic atrophies.
Jimi T; Wakayama Y; Matsuzaki Y; Hara H; Inoue M; Shibuya S
Pathol Res Pract; 2004; 200(3):203-9. PubMed ID: 15200272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
